Details of the Drug
General Information of Drug (ID: DMHCWY8)
| Drug Name |
8-methoxy-2-oxo-2H-chromene-3-carboxylic acid
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
8-Methoxy-2-oxo-2H-chromene-3-carboxylic acid; 2555-20-6; 8-methoxy-2-oxochromene-3-carboxylic acid; 8-methoxycoumarin-3-carboxylic acid; CHEMBL568348; SFAPWVZFUHJZIC-UHFFFAOYSA-N; 2H-1-Benzopyran-3-carboxylic acid, 8-methoxy-2-oxo-; NSC34647; AC1L5SHQ; AC1Q5T4B; 3-Carboxy-8-methoxycoumarin; Oprea1_510137; Oprea1_497732; 8-methoxy-3-carboxy-coumarin; SCHEMBL980310; methoxyoxochromenecarboxylicacid; SCHEMBL3659230; ZINC84532; KS-00001VYM; CTK4F6014; DTXSID30283980; MolPort-000-145-720; ALBB-000306; NSC-34647; STK411116; BBL013903
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 220.18 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.2 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||||||||


